Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
about
Chronic beryllium disease: an updated model interaction between innate and acquired immunityThe uses and adverse effects of beryllium on healthPulmonary fibrosis in response to environmental cues and molecular targets involved in its pathogenesisBeryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen GenerationDNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent VirusTrace elements and carcinogenicity: a subject in reviewDeficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium diseaseBlockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium diseaseCD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung.Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjectsBeryllium-specific CD4+ T cells in blood as a biomarker of disease progression.Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory.Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.Genetic, Immunologic, and Environmental Basis of Sarcoidosis.Immunologic Effects of Beryllium Exposure.PD-1 Expression on -Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
P2860
Q28386885-910B471E-2A89-40A9-85EF-2650683E5201Q28394525-29CF9555-A54F-4517-B1FB-1B05F84B608DQ28394670-3F755A64-5179-44B5-9FB4-72584AF1D4ABQ28396954-483A4650-5F4E-4A10-8443-ED7E79CB5DFFQ28554534-A916C2D6-D53B-4D2A-8DE8-FACF707E75BEQ28703619-D7D18FDB-010D-4C63-BACD-42329E15A787Q33938362-AC3DEDEE-75C6-4984-887B-4EECACF9E319Q34353222-3D6DCE75-47D9-4829-8F79-A4D0A0C0D700Q34425775-608E1237-EE2E-4445-B278-8C7AD92329BDQ34670370-DE00CA41-9D23-4A76-820B-D3ECA8DE92D4Q34702659-FD1B8406-FE60-4D24-B6A6-576712ADCB2BQ35153496-7F8AF4A3-0222-4439-9771-99619084E216Q35488913-42E49F70-438D-436C-99B5-1062782EB361Q37114482-6E344DE0-1DDB-4FDE-B642-C2FB635E84F5Q41963165-337AFC2E-AA5F-40E1-B97C-DB684759809CQ42706504-4C52181C-93F2-4AA3-A71F-391CDF6FFF3FQ47233198-29B30010-1ABF-4B6E-9836-4E3074F87D36Q52314412-BF80D7D6-F706-4E4B-9402-4B6EF1D7AB7AQ57166485-1BB760BB-89A4-4BB4-82A6-D3C2C169D737
P2860
Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Up-regulation of programmed de ...... in chronic beryllium disease.
@ast
Up-regulation of programmed de ...... in chronic beryllium disease.
@en
type
label
Up-regulation of programmed de ...... in chronic beryllium disease.
@ast
Up-regulation of programmed de ...... in chronic beryllium disease.
@en
prefLabel
Up-regulation of programmed de ...... in chronic beryllium disease.
@ast
Up-regulation of programmed de ...... in chronic beryllium disease.
@en
P2093
P2860
P1476
Up-regulation of programmed de ...... in chronic beryllium disease.
@en
P2093
Allison K Martin
Andrew P Fontenot
Brent E Palmer
Douglas G Mack
Lisa A Maier
Margaret M Mroz
May Gillespie
P2860
P304
P356
10.4049/JIMMUNOL.180.4.2704
P407
P577
2008-02-01T00:00:00Z